Related Experiment Video
Updated: Jan 16, 2026
Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
Published on: June 11, 2014
Incorporating Continuous Mammographic Density Into the BOADICEA Breast Cancer Risk Prediction Model
Lorenzo Ficorella1, Mikael Eriksson1,2, Kamila Czene2
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Purpose:
Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA v7) predicts future breast cancer (BC) risk using data on cancer family history (FH), genetic markers, questionnaire-based risk factors, and mammographic density (MD) measured using the four-category Breast Imaging Reporting and Data System (BIRADS) classification. However, BIRADS requires manual reading, which is impractical on a large scale and may cause information loss. We extended BOADICEA to incorporate continuous MD measurements, calculated using the automated Volpara and STRATUS tools.
Methods:
We used data from the Karolinska Mammography Project for Risk Prediction of Breast Cancer cohort (60,276 participants; 1,167 incident BC). Associations between MD measurements and BC risk were estimated in a randomly selected training subset (two thirds of the data set). Percent MD residuals were calculated after regressing on age at mammography and BMI. Hazard ratios (HRs) were estimated using a Cox proportional hazards model, adjusting for FH and BOADICEA risk factors, and were incorporated into BOADICEA. The remaining one third of the cohort was used to assess the performance of the extended BOADICEA (v7.2) in predicting 5-year risks.
Results:
The BC HRs per standard deviation of residual STRATUS density were estimated to be 1.48 (95% CI, 1.33 to 1.64) and 1.41 (95% CI, 1.27 to 1.56) for pre- and postmenopausal women, respectively. The corresponding estimates for Volpara density were 1.27 (95% CI, 1.15 to 1.40) and 1.38 (95% CI, 1.25 to 1.54). The extended BOADICEA showed improved discrimination in the testing data set over using BIRADS, with a 1%-4% increase in AUC across different combinations of risk factors. On the basis of 5-year BC risk with MD as the sole input, approximately 11% of the women were reclassified into lower risk categories and 18% into higher risk categories using the extended model.
Conclusion:
Incorporating continuous MD measurements into BOADICEA enhances BC risk stratification and facilitates the use of automated MD measures for risk prediction.
